Orange Medipharmaceuticals Private Limited, a active private limited company, was established on 05 November 2015 in Lucknow, Uttar Pradesh, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24233UP2015PTC074326. Registered under ROC Roc Kanpur. it is unlisted. It has an authorized capital of ₹2.50 M and a paid-up capital of ₹2.24 M.
It upholds a compliant status. Its leadership includes Imran Ahmad Ansari (Director), Humera Yaseen (Director), Abdullah Saleh Salmen Anooz Al Ameri (Director). Past directors included Abdullah Saleh Salmen Anooz Al Ameri. It holds ₹4.00 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at H.No. 631/168-A, Rajeev Nagar Ismail Ganj, Ward-Ii, Lucknow, Uttar Pradesh, 226016.
U24233UP2015PTC074326
074326
05 November 2015
₹2.50 M
₹2.24 M
Roc Kanpur
Unlisted
Active
Explore comprehensive insights into Orange Medipharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Imran Ahmad Ansari | Director | 05 Nov 2015 | Current |
| Humera Yaseen | Director | 05 Nov 2015 | Current |
| Abdullah Saleh Salmen Anooz Al Ameri | Director | 17 May 2017 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2017 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Orange Medipharmaceuticals Private Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 38.68% decrease. The company also saw a substantial improvement in profitability, with a 9143.84% increase in profit. The company's net worth observed a substantial decline by a decrease of 14.58%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2020, Orange Medipharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹4,000,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 23 Jun 2021 | Others | ₹4.00 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Orange Medipharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Orange Medipharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Orange Medipharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Orange Medipharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
Progress on Orange Medipharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Kanpur. was documented.
A charge with Others amounted to Rs. 4.00 M with Charge ID 100455254 was registered on 23 Jun 2021. was recorded as a recent event.
The activity Abdullah Saleh Salmen Anooz Al Ameri was appointed as a Director was appointed as a Director on 17 May 2017 & has been associated with this company since 8 years 6 months . was completed.
Imran Ahmad Ansari was appointed as a Director was appointed as a Director on 05 Nov 2015 & has been associated with this company since 10 years 26 days . was recorded as a recent event.
The activity Humera Yaseen was appointed as a Director was appointed as a Director on 05 Nov 2015 & has been associated with this company since 10 years 26 days . was completed.
The CIN of Orange Medipharmaceuticals Private Limited is U24233UP2015PTC074326.
Orange Medipharmaceuticals Private Limited is headquartered at H.No. 631/168-A, Rajeev Nagar Ismail Ganj, Ward-Ii, Lucknow, Uttar Pradesh, 226016.
Orange Medipharmaceuticals Private Limited was incorporated on 05 November 2015.
The current directors of Orange Medipharmaceuticals Private Limited are
The primary industry of Orange Medipharmaceuticals Private Limited is Trade.
Orange Medipharmaceuticals Private Limited is unlisted.
The authorized capital of Orange Medipharmaceuticals Private Limited is ₹2.50 M, and the paid-up capital is ₹2.24 M.
The compliance status of Orange Medipharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX